These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9099433)

  • 21. Effectively incorporating risk management into quality systems.
    Donawa M
    Med Device Technol; 2006 Jun; 17(5):28-30. PubMed ID: 16903387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A practical approach to designing operating instructions for medical products in late or post-design phases.
    Gupta SP; Lyons M
    J Med Eng Technol; 2009; 33(3):238-44. PubMed ID: 19340695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health device legislation: an overview of the law and its impact on respiratory care.
    Bancroft ML; Steen JA
    Respir Care; 1978 Dec; 23(12):1179-84. PubMed ID: 10315033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differing definitions of manufacturer.
    Donawa ME
    Med Device Technol; 1998; 9(6):14-7. PubMed ID: 10182120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical devices; device tracking; new orders to manufacturers--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10638-40. PubMed ID: 10177504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Working draft of the FDA GMP final rule (Part II).
    Donawa ME
    Med Device Technol; 1995 Nov; 6(9):9-12. PubMed ID: 10158131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taking control: the Validation Master Plan.
    Donawa ME
    Med Device Technol; 1995 Dec; 6(10):12-4. PubMed ID: 10158118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. US quality system requirements for software validation.
    Donawa ME
    Med Device Technol; 1998 Mar; 9(2):17-20. PubMed ID: 10186973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public information; communications with state and foreign government officials--FDA. Proposed rule.
    Fed Regist; 1998 Jul; 63(143):40069-72. PubMed ID: 10181518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meeting European and US requirements for design and development documentation, Part II.
    Donawa ME
    Med Device Technol; 1996 Dec; 7(10):10-5. PubMed ID: 10164052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical devices; medical device, user facility, distributor, and manufacturer reporting, certification, and registration--FDA. Tentative final rule.
    Fed Regist; 1991 Nov; 56(228):60024-39. PubMed ID: 10115705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the regulatory requirements for dialysate.
    Ward RA
    Nephrol News Issues; 1991 Jan; 5(1):13, 15. PubMed ID: 1961262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human factors and the FDA's goals: improved medical device design.
    Burlington DB
    Biomed Instrum Technol; 1996; 30(2):107-9. PubMed ID: 8673158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why compliance is not good enough.
    Kossovsky N; Brandegee B
    J Biomed Mater Res; 1999; 48(1):1-4. PubMed ID: 10029141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Simple Suggestion of Adapting Requirements of Medical Devices New Supervision Regulation System for Medical Device Manufacturers].
    Li Y; Chu Z; Fan Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 May; 41(3):220-223. PubMed ID: 29862773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating risk management into the CAPA process.
    Bills E; Tartal J
    Biomed Instrum Technol; 2008; 42(6):466-8. PubMed ID: 19012461
    [No Abstract]   [Full Text] [Related]  

  • 39. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design considerations for medical device manufacturers.
    Patel A; Pope J; Neilson M
    Biomed Instrum Technol; 2012; Suppl():73-5. PubMed ID: 22559781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.